---
authors:
- ReactomeTeam
description: Interleukin-12 (IL-12) is a heterodimer of interleukin-12 subunit alpha
  (IL12A, IL-12p35) and interleukin-12 subunit beta (IL12B, IL-12p40). It is a potent
  immunoregulatory cytokine involved in the generation of cell mediated immunity to
  intracellular pathogens. It is produced by antigen presenting cells, including dendritic
  cells, macrophages/monocytes, neutrophils and some B cells (D'Andrea et al. 1992,
  Kobayashi et al.1989, Heufler et al.1996). It enhances the cytotoxic activity of
  natural killer (NK) cells and cytotoxic T cells, stimulating proliferation of activated
  NK and T cells and induces production of interferon gamma (IFN gamma) by these cells
  (Stern et al. 1990). IL-12 also plays an important role in immunomodulation by promoting
  cell mediated immunity through induction of a class 1 T helper cell (Th1) immune
  response.  IL-12 may contribute to immunopathological conditions such as rheumatoid
  arthritis (McIntyre et al. 1996). The receptor for IL-12 is a heterodimer of IL-12Rbeta1
  (IL12RB1) and IL-12Rbeta2 (IL12RB2), both highly homologous to Interleukin-6 receptor
  subunit beta (IL6ST,gp130). Each has an extracellular ligand binding domain, a transmembrane
  domain and a cytosolic domain containing box 1 and box 2 sequences that mediate
  binding of Janus family tyrosine kinases (JAKs). IL-12 binding is believed to bring
  about the heterodimerization and generation of a high affinity receptor complex
  capable of signal transduction. In this model, receptor dimerization leads to juxtaposition
  of the cytosolic domains and subsequent tyrosine phosphorylation and activation
  of JAK2 and TYK2. These activated kinases, in turn, tyrosine phosphorylate and activate
  several members of the signal transducer and activator of transcription (STAT) family,
  mainly STAT4, while also STAT1, STAT3 and STAT5 have been reported to be activated
  (Bacon et al. 1995, Jacobson et al. 1995, Yu et al. 1996, Gollob et al.1995). The
  STATs translocate to the nucleus to activate transcription of several genes, including
  IFN gamma. The production of IFN gamma has a pleiotropic effect in the cell, stimulating
  production of molecules important to cell mediated immunity. In particular, IFN
  gamma stimulates production of more IL-12 and sets up a positive regulation loop
  between IL-12 signaling and IFN gamma (Chan et al. 1991). The importance of IL-12
  for this loop is demonstrated by IL-12 and STAT4 knockout mice that are severely
  compromised in IFN-gamma production (Kaplan et al. 1996; Magram et al. 1996), as
  well as by patients with IL12B mutations that are severely compromised in IFN-gamma
  production (Altare et al.1998).  View original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=447115
  Reactome].
last-edited: 2021-01-25
organisms:
- Homo sapiens
redirect_from:
- /index.php/Pathway:WP4052
- /instance/WP4052
schema-jsonld:
- '@context': https://schema.org/
  '@id': https://wikipathways.github.io/pathways/WP4052.html
  '@type': Dataset
  creator:
    '@type': Organization
    name: WikiPathways
  description: Interleukin-12 (IL-12) is a heterodimer of interleukin-12 subunit alpha
    (IL12A, IL-12p35) and interleukin-12 subunit beta (IL12B, IL-12p40). It is a potent
    immunoregulatory cytokine involved in the generation of cell mediated immunity
    to intracellular pathogens. It is produced by antigen presenting cells, including
    dendritic cells, macrophages/monocytes, neutrophils and some B cells (D'Andrea
    et al. 1992, Kobayashi et al.1989, Heufler et al.1996). It enhances the cytotoxic
    activity of natural killer (NK) cells and cytotoxic T cells, stimulating proliferation
    of activated NK and T cells and induces production of interferon gamma (IFN gamma)
    by these cells (Stern et al. 1990). IL-12 also plays an important role in immunomodulation
    by promoting cell mediated immunity through induction of a class 1 T helper cell
    (Th1) immune response.  IL-12 may contribute to immunopathological conditions
    such as rheumatoid arthritis (McIntyre et al. 1996). The receptor for IL-12 is
    a heterodimer of IL-12Rbeta1 (IL12RB1) and IL-12Rbeta2 (IL12RB2), both highly
    homologous to Interleukin-6 receptor subunit beta (IL6ST,gp130). Each has an extracellular
    ligand binding domain, a transmembrane domain and a cytosolic domain containing
    box 1 and box 2 sequences that mediate binding of Janus family tyrosine kinases
    (JAKs). IL-12 binding is believed to bring about the heterodimerization and generation
    of a high affinity receptor complex capable of signal transduction. In this model,
    receptor dimerization leads to juxtaposition of the cytosolic domains and subsequent
    tyrosine phosphorylation and activation of JAK2 and TYK2. These activated kinases,
    in turn, tyrosine phosphorylate and activate several members of the signal transducer
    and activator of transcription (STAT) family, mainly STAT4, while also STAT1,
    STAT3 and STAT5 have been reported to be activated (Bacon et al. 1995, Jacobson
    et al. 1995, Yu et al. 1996, Gollob et al.1995). The STATs translocate to the
    nucleus to activate transcription of several genes, including IFN gamma. The production
    of IFN gamma has a pleiotropic effect in the cell, stimulating production of molecules
    important to cell mediated immunity. In particular, IFN gamma stimulates production
    of more IL-12 and sets up a positive regulation loop between IL-12 signaling and
    IFN gamma (Chan et al. 1991). The importance of IL-12 for this loop is demonstrated
    by IL-12 and STAT4 knockout mice that are severely compromised in IFN-gamma production
    (Kaplan et al. 1996; Magram et al. 1996), as well as by patients with IL12B mutations
    that are severely compromised in IFN-gamma production (Altare et al.1998).  View
    original pathway at [http://www.reactome.org/PathwayBrowser/#DIAGRAM=447115 Reactome].
  keywords:
  - 'IL27 '
  - 'p-JAK1 '
  - 2xIL12B
  - IL-35:(IL6ST:p-JAK1:p-JAK2) dimer:p-STAT1
  - 'p-Y611-IL27RA '
  - CANX
  - IL35:IL6ST:p-JAK1:IL12RB2:p-JAK2
  - IL27:EBI3:p-Y611-IL27RA:p-JAK1:p-Y-IL6ST:p-JAK1,p-JAK2,p-TYK2
  - stimulation
  - CRLF1:IL27
  - IL12A:IL12B:IL12RB1:p-Y-TYK2:IL12RB2:p-JAK2
  - p-Y701-STAT1
  - 'STAT1 '
  - after
  - 'EBI3 '
  - IL12A gene
  - Y963-STAT4 dimer
  - p-Y693-STAT4:p-Y701-STAT1
  - P4HB
  - p-Y693-STAT4 dimer
  - EBI3 gene
  - IL23A:IL12B:IL12RB1:p-TYK2:p-Y-IL23R:p-JAK2:STAT3
  - IL12A:IL12B:IL12RB1:p-Y800-IL12RB2:p-Y-TYK2:p-JAK2
  - 'p-Y693-STAT4 '
  - IL27
  - (TYK2)
  - IL-35:IL27RA:p-JAK1:IL12RB2:p-JAK2:p-STAT1:p-STAT3
  - p-Y693-STAT4:p-Y701-STAT1:EBI3 gene
  - STAT4
  - p-Y693-STAT4:p-Y701-STAT1:IL12A gene
  - p-Y701-STAT1:p-Y705-STAT3:IL27:EBI3:p-Y611-IL27RA:p-JAK1:p-Y-IL6ST:p-JAK1,p-JAK2,p-TYK2
  - IL35:IL27RA:p-JAK1:IL12RB2:p-JAK2:STAT1:STAT3
  - 'p-Y701-STAT1 '
  - ATP
  - STAT3
  - IL23A:IL12B:IL23R:JAK2:IL12RB1:TYK2
  - dimer)
  - 'IL6ST '
  - p-STAT1:p-STAT4
  - 'p-STAT4 '
  - IL12A
  - IL35:IL6ST:p-JAK1:IL12RB2:p-JAK2:p-STAT1:p-STAT4
  - sIL27RA
  - IL12B:IL23A
  - IL27:EBI3:IL27RA:JAK1:IL6ST:JAK1,JAK2,(TYK2)
  - 'IL-35:(IL6ST:p-JAK1:p-JAK2) dimer: STAT1'
  - 'CRLF1 '
  - Gene and protein
  - IL6ST
  - 'p-Y705-STAT3 '
  - CANX:EBI3:IL12A
  - 'STAT3 '
  - 'IL12RB1 '
  - STAT1
  - IL12RB2
  - JAK2
  - IL12RB1
  - 'IL12A gene '
  - 'p-Y-IL23R '
  - IL35:IL6ST:JAK1:IL12RB2:JAK2
  - IL12RB1:TYK2:IL12RB2:JAK2
  - 2xp-Y693-STAT4:IL12A:IL12B:IL12RB1:p-Y800-IL12RB2:p-Y-TYK2:p-JAK2
  - CANX:EBI3
  - 'CANX '
  - IL12RB1:TYK2
  - 'TYK2 '
  - 'IL12B '
  - IL35:(IL6ST:p-JAK1:p-JAK2:p-TYK2) dimer
  - IL27:EBI3
  - p-STAT1
  - IL12A:EBI3
  - 'JAK2 '
  - 'p-STAT1 '
  - IL12A:IL12B
  - IL23A:IL12B:IL12RB1:p-TYK2:p-Y-IL23R:p-JAK2:STAT3:STAT4
  - 'IL23A '
  - 'p-Y-TYK2 '
  - ' The identified upregulated proteins are:  BOLA2, PSME2,  MTAP, CA1,  GSTA2,  RALA,  CNN2,  CFL1,  TCP1,  HNRNPDL,  MIF,  AIP,  SOD1,
    PPIA and  PDCD4.<br>And the identified downregulated proteins are:<br>ANXA2, RPLP0,
    CAPZA1, SOD2, SNRPA1, LMNB1, LCP1, HSPA9, SERPINB2, HNRNPF, TALDO1, PAK2, TCP1,
    HNRNPA2B1, MSN, PITPNA, ARF1, SOD2, ANXA2, CDC42, RAP1B and GSTO1.'
  - CANX:EBI3:IL27
  - IL12A:IL12B:IL12RB1:p-Y800-IL12RB2:p-Y-TYK2:p-JAK2:2xSTAT4
  - JAK1, JAK2, (TYK2)
  - IL27RA
  - IL23A
  - Interleukin-12
  - IL27:EBI3:p-Y611-IL27RA:p-JAK1:p-Y-IL6ST:p-JAK1,p-JAK2,p-Y-TYK2:STAT1:STAT3
  - IL23R
  - IL35:IL6ST:p-JAK1:IL12RB2:p-JAK2:STAT1:STAT4
  - IL12RB2:JAK2
  - p-Y701-STAT1:p-Y705-STAT3
  - IL-35:(IL6ST:JAK1:JAK2) dimer
  - IL23A:IL12B:IL12RB1:p-TYK2:p-Y-IL23R:p-JAK2:p-Y705-STAT3:p-Y693-STAT4
  - 'EBI3 gene '
  - IL35:(IL12RB2:JAK2
  - 'p-Y800-IL12RB2 '
  - p-Y705-STAT3
  - 'STAT4 '
  - IL35:IL27RA:p-JAK1:IL12RB2:p-JAK2
  - IL35
  - IL35:(IL12RB2:p-JAK2) dimer:STAT4
  - 2xIL27RA
  - VAMP7
  - 'p-STAT3 '
  - 'p-TYK2 '
  - p-STAT4
  - CRLF1
  - IL23A:IL12B:IL12RB1:p-TYK2:p-Y-IL23R:p-JAK2
  - JAK1
  - 'IL23R '
  - IL35:(IL12RB2:p-JAK2) dimer
  - IL35:IL27RA:JAK1:IL12RB2:JAK2
  - expression by
  - 'IL12RB2 '
  - IL12B
  - 'p-Y-IL6ST '
  - p-Y705-STAT3:p-Y693-STAT4
  - IL27:EBI3:IL27RA:p-JAK1:IL6ST:p-JAK1,p-JAK2,p-TYK2
  - IL12A:IL12RB1:TYK2:IL12B:IL12RB2:JAK2
  - 'IL27RA '
  - ADP
  - 'p-JAK2 '
  - IL27RA:JAK1
  - p-STAT3
  - IL35:(IL12RB2:p-JAK2) dimer:p-STAT4
  - EBI3
  - JAK-STAT signaling
  - IL6ST:JAK1, JAK2,
  - TYK2
  - IL-35:(IL6ST:p-JAK1:p-JAK2) dimer
  - 'IL12A '
  - IL23R:JAK2
  - IL23A:IL12B:IL12RB1:p-TYK2:IL23R:p-JAK2
  - p-Y693-STAT4
  - 'JAK1 '
  license: CC0
  name: Interleukin-12 family signaling
seo: CreativeWork
title: Interleukin-12 family signaling
wpid: WP4052
---